Related Experiment Video

Updated: May 24, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

A retrospective study of bacterial infections in cirrhosis

Carmen Monica Preda1, Ruxandra Ghita, Camelia Ghita

  • 1Centrul de Gastroenterologie si Hepatologie, Institutul Clinic Fundeni, Bucuresti.

Maedica
|February 28, 2012
PubMed

Insights

Bacterial infections (BI) occur in 4.9% of hepatic cirrhosis (HC) patients, with decompensated cirrhosis and upper GI bleeding as key risk factors. Early detection of BI in hospitalized HC patients is crucial for improved outcomes.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Hepatic cirrhosis (HC) is a significant global health concern.
  • Bacterial infections (BI) are common complications in patients with HC.
  • Understanding the incidence, pathogens, risk factors, and prognostic impact of BI in HC is essential for patient management.

Purpose of the Study:

  • To determine the incidence of bacterial infections in patients with hepatic cirrhosis.
  • To identify the causative pathogen agents of bacterial infections in HC.
  • To define the risk factors and assess the impact of bacterial infections on the prognosis of hepatic cirrhosis.

Main Methods:

  • A retrospective study involving 1046 patients with HC admitted between October 1, 2008, and March 31, 2009.
  • Monitoring of clinical, biological, and bacteriological data.
  • Analysis of infection sites, acquired sources (community vs. nosocomial), and identified etiologic agents.

Main Results:

  • The incidence of BI in HC was 4.9% (51 patients).
  • Common infection sites included peritoneal (26), urinary (20), and pneumonia (8).
  • Decompensated HC (OR=58.23) and Child Pugh score C (OR=1.99) were significant risk factors for BI. ICU admission for BI had an 83% mortality rate.

Conclusions:

  • The observed BI rate of 4.9% in HC is lower than literature (15-30%), likely due to the retrospective nature focusing on severe infections.
  • Active surveillance for infections in all hospitalized HC patients is recommended.
  • Particular attention should be given to patients with decompensated cirrhosis and upper GI bleeding.
Abstract

Keywords:
bacterial infectionliver cirrhosisspontaneous bacterial peritonitisupper gastrointestinal bleeding

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...